Skip to main content

Advertisement

Log in

Differences between women and men in serial HIV prevalence and incidence trends

  • INFECTIOUS DISEASES
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

To measure trends in HIV incidence and serial prevalence by sex in a intravenous drug users (IDUs) and heterosexuals (HT) cohort recruited in a counselling centre in Valencia (1988–2005). Serial prevalence and incidence rates were calculated and modelled by logistic and Poisson regression respectively. 5948 IDUs and 13343 HT were recruited. Prevalence was higher among female IDUs (46% vs. 41%), and female HT (4.1% vs. 2%). For IDUs, an interaction (P = 0.005) between sex and calendar was detected. Age-adjusted prevalence showed faster yearly decline in men (OR = 0.87 95%CI: 0.85–0.88) than in women (OR = 0.91 95%CI: 0.88–0.93). Incidence was higher in female IDUs (9.79% p-y) than in men, (5.38% p-y) with an annual decrease for both of 11%. HIV incidence was higher in female HT (0.62% p-y) compared to men 0.23% p-y with a 21% yearly decline. Gender differences in HIV prevalence and incidence trends have been detected. Women showed an increased vulnerability to infection in a country whose HIV epidemic has been largely driven by IDUs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

CIPS:

Centre for AIDS Information and Prevention

HT:

Heterosexuals

HAV:

Hepatitis A virus

HBV:

Hepatitis B virus

HCV:

Hepatitis C virus

IDU:

Intravenous drug users

RR:

Rates ratio

References

  1. Rice BD, Payne LJ, Sinka K, Patel B, Evans BG, Delpech V. The changing epidemiology of prevalent diagnosed HIV infections in England, Wales, and Northern Ireland, 1997 to 2003. Sex Transm Infect. 2005;81:223–9. doi:10.1136/sti.2004.012070.

    Article  PubMed  CAS  Google Scholar 

  2. UNAIDS. Report on the global AIDS epidemic. Geneva. (2006).

  3. EuroHIV. HIV/AIDS surveillance in Europe. Saintt-Maurice: Institut de la Veille Sanitarie; 2005.

    Google Scholar 

  4. Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science. 2005;308:1582–3. doi:10.1126/science.1112489.

    Article  PubMed  CAS  Google Scholar 

  5. ONUSIDA. Situación sobre la epidemia de SIDA. www.onusida.org (2005).

  6. De La Fuente L, Bravo MJ, Toro C, et al. Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes. J Epidemiol Community Health. 2006;60:537–42. doi:10.1136/jech.2005.037333.

    Article  PubMed  Google Scholar 

  7. De La Fuente L, Bravo MJ, Barrio G, et al. Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors. Clin Infect Dis. 2003;37(Suppl 5):S410–5. doi:10.1086/377562.

    Article  Google Scholar 

  8. Barrasa A, del Romero J, Pueyo I, et al. Prevalence of the HIV infection in patients seen at specialized diagnosis centers in 9 cities in Spain from 1992 to 2001. Aten Primaria. 2004;33:483–8. doi:10.1157/13061610.

    Article  PubMed  CAS  Google Scholar 

  9. Jesús Castilla J, Lorenzo JM, Izquierdo A, et al. Características y tendencias de los nuevos diagnósticos de infección por el VIH, 2000–2004. Gac Sanit. 2006;20(6):442–8. doi:10.1157/13096525.

    Article  PubMed  Google Scholar 

  10. Hurtado I, Alastrue I, Ferreros I, et al. Trends in HIV testing, serial HIV prevalence and HIV incidence among persons attending a Center for AIDS Prevention from 1988 to 2003. Sex Transm Infect. 2007;83:23–8. doi:10.1136/sti.2005.019299.

    Article  PubMed  CAS  Google Scholar 

  11. Kim H-J, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–51. doi:10.1002/(SICI)1097-0258(20000215)19:3≤335::AID-SIM336≥3.0.CO;2-Z.

    Article  PubMed  CAS  Google Scholar 

  12. National Cancer Institute. Statistical research and applications branch [on-line]. http://srab.cancer.gov/software/joinpoint.html. 19-3-2005.

  13. Stata Corp. Stata Statistical Sofware:Release 8.0. 2003.

  14. Spittal PM, Craib KJ, Wood E, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ. 2002;166:894–9.

    PubMed  Google Scholar 

  15. Lum PJ, Sears C, Guydish J. Injection risk behavior among women syringe exchangers in San Francisco. Subst Use Misuse. 2005;40:1681–96. doi:10.1080/10826080500222834.

    Article  PubMed  Google Scholar 

  16. Riehman KS, Kral AH, Anderson R, Flynn N, Bluthenthal RN. Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors. J Urban Health. 2004;81:249–59. doi:10.1093/jurban/jth111.

    PubMed  Google Scholar 

  17. Mehta SH, Galai N, Astemborski J, et al. HIV incidence among injection drug users in Baltimore, Maryland (1988–2004). J Acquir Immune Defic Syndr. 2006;43:368–72. doi:10.1097/01.qai.0000243050.27580.1a.

    Article  PubMed  Google Scholar 

  18. Fuente de Hoz L, Brugal Puig MT, Ballesta Gómez R, et al. Metodología del estudio de cohortes del proyecto ITINERE sobre consumidores de heroína en tres ciudades españolas y características básicas de los participantes. Rev Esp Salud Publica. 2005;79:475–91. doi:10.1590/S1135-57272005000400005.

    Article  PubMed  Google Scholar 

  19. Jarlais D. The first and second decades of AIDS among injecting drug users. Br J Addict. 1992;87:347–53. doi:10.1111/j.1360-0443.1992.tb01935.x.

    Article  PubMed  Google Scholar 

  20. Whynot EM. Women who use injection drugs: the social context of risk. CMAJ. 1998;159:355–8.

    PubMed  CAS  Google Scholar 

  21. Barrasa A, Castilla J, del Romero J, et al. Sentinel surveillance of HIV infection in HIV test clinics, Spain 1992–2002. Euro Surveill. 2004;9:27–9.

    PubMed  CAS  Google Scholar 

  22. Turmen T. Gender and HIV/AIDS. Int J Gynaecol Obstet. 2003;82:411–8. doi:10.1016/S0020-7292(03)00202-9.

    Article  PubMed  CAS  Google Scholar 

  23. Gatali M, Archibald C. Women and HIV. BMC Womens Health. 2004;4(Suppl 1):S27. doi:10.1186/1472-6874-4-S1-S27.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Sponsorship: This work was financed through grants from Fondo de Investigación Sanitaria (FIS) (02/0639) and Becas de la Consellería de Sanitat de la Generalitat Valenciana B12/03 y B15/04.

Authorship: I. Hurtado, designed the study, I Hurtado and S Pérez-Hoyos carried out the statistical analysis. I. Alastrue, C. Santos and T. Tasa were responsible for the recruitment and data collection. S. Pérez-Hoyos set up the original study and collaborated in its design. I. Hurtado, S. Pérez-Hoyos and J. Del Amo wrote and interpreted the results. All the authors revised the different versions of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Isabel Hurtado Navarro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hurtado Navarro, I., Alastrue, I., del Amo, J. et al. Differences between women and men in serial HIV prevalence and incidence trends. Eur J Epidemiol 23, 435–440 (2008). https://doi.org/10.1007/s10654-008-9246-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-008-9246-2

Keywords

Navigation